PRME - Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
2023-05-26 09:45:00 ET
Cathie Wood is always making moves. The CEO, co-founder, and rock-star stock picker for the Ark Investment family of exchange-traded funds (ETFs) publishes her transactions at the end of every trading day. What's she buying these days?
The growth-stock investor added to her stakes in UiPath (NYSE: PATH) , Prime Medicine (NASDAQ: PRME) , and Adaptive Biotechnologies (NASDAQ: ADPT) on Thursday. What does Wood see in these three somewhat off-the-radar companies? Let's take a closer look.
Shares of UiPath tumbled 11% on Thursday, despite posting seemingly strong quarterly results. Revenue rose a better-than-expected 18% for the fiscal quarter that ended in April, well ahead of the 11% gain that analysts were targeting. The provider of robotics and automation software solutions also trounced profit estimates, something that it has consistently done over the past year.
For further details see:
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought